Jade Biosciences Cash Flow Statement
NASDAQ: JBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.39+0.24 (+1.70%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Jade Biosciences free cash flow
In fiscal 2025, Jade Biosciences generated -$94.7 million of operating cash flow and spent $196,000 on capital expenditures. That left free cash flow of -$94.9 million.
Summary generated from market data by MetaCap's automated system. Methodology
Jade Biosciences cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Net Income | -127.41M | -69.63M | -75.52M | -51.51M | -22.96M | -9.61M |
| Net Income growth (YoY) | — | — | — | — | — | — |
| Depreciation & Amortization | 26.00K | 282.00K | 96.00K | 68.00K | 15.00K | 1.00K |
| Stock-Based Compensation | 20.01M | 11.31M | 11.91M | 5.48M | 2.04M | 58.00K |
| Change in Working Capital | -11.61M | -1.71M | -65.00K | 5.91M | -6.25M | -66.00K |
| Operating Cash Flow | -94.69M | -71.20M | -56.78M | -39.12M | -27.40M | -7.86M |
| Capital Expenditures | -196.00K | — | -142.00K | -195.00K | -181.00K | — |
| Investing Cash Flow | -247.01M | 56.03M | 11.88M | 6.93M | -113.43M | — |
| Financing Cash Flow | 360.77M | 25.43M | 46.00M | 396.00K | 190.46M | 8.92M |
| Net Change in Cash | 19.05M | 10.26M | 1.09M | -31.80M | 49.62M | 1.06M |
| Free Cash Flow | -94.89M | -71.20M | -56.92M | -39.32M | -27.58M | -7.86M |
This table shows 6 annual periods of Jade Biosciences's cash flow statement, from FY 2025 back to FY 2020, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow JBIO's reporting calendar. What is a cash flow statement?